BioMimetic Therapeutics, Inc. · Franklin, TN United States (NASDAQ: BMTI)
| 389-A Nichol Mill Ln. | Phone: 615-844-1280 |
| Franklin, TN | Fax: 615-844-1281 |
| 37067 | |
| United States | 
Map This Company |
BioMimetic Therapeutics, Inc. Rankings
More Companies in These Related Industries: Surgical & Medical Instrument Mfg, Personal Safety Equipment Mfg, Pharmaceutical Preparation MfgCompany Description
BioMimetic Therapeutics' GEM might not sparkle, but it does attract cells that promote tissue and bone growth when applied to damaged tissue or a bone fracture. The company's product candidates are based on the GEM (Growth-factor Enhanced Matrix) technology, a combination drug and medical device platform that includes a human tissue growth factor with a synthetic bone matrix. BioMimetic Therapeutics is working to develop the GEM technology as a treatment for various fractures, where its bone matrix can be used to repair, reinforce, or fuse broken bones, as well as repair tendons, ligaments, and cartilage. The company is focused on orthopedic, spine, and sports injuries.
BioMimetic Therapeutics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: BMTI Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 95 |
Executives
18 executives listed for BioMimetic Therapeutics, Inc.'s Franklin, TN location.
| Chairman | Larry Papasan | |
|---|---|---|
| President, CEO, and Director | Samuel Lynch | |
| CFO and Corporate Secretary | Lawrence Bullock |